Symbol="MRUS"
AssetType="Common Stock"
Name="Merus BV"
Description="Merus NV, a clinical-stage immuno-oncology company, is dedicated to the discovery and development of bispecific antibody therapies in the Netherlands. The company is headquartered in Utrecht, the Netherlands."
CIK="1651311"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="YALELAAN 62, 3584 CM UTRECHT, NL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1128042000"
EBITDA="-170620000"
PERatio="None"
PEGRatio="0"
BookValue="5.16"
DividendPerShare="0"
DividendYield="0"
EPS="-3.34"
RevenuePerShareTTM="0.883"
ProfitMargin="0"
OperatingMarginTTM="-4.184"
ReturnOnAssetsTTM="-0.267"
ReturnOnEquityTTM="-0.611"
RevenueTTM="41222000"
GrossProfitTTM="-107838000"
DilutedEPSTTM="-3.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.174"
AnalystTargetPrice="45.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.19"
PriceToBookRatio="2.148"
EVToRevenue="6.65"
EVToEBITDA="-2.372"
Beta="0.808"
num_52WeekHigh="27.7"
num_52WeekLow="12.03"
num_50DayMovingAverage="25.38"
num_200DayMovingAverage="19.76"
SharesOutstanding="49803200"
DividendDate="None"
ExDividendDate="None"
symbol="MRUS"
open="23.14"
high="23.64"
low="22.48"
price="22.62"
volume="250503.00"
latest_trading_day="2023-08-11"
previous_close="22.90"
change="-0.28"
change_percent="-1.2227%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="373173"
Change_recent_avg="-0.03"
Delta_recent_avg="1.29"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_negative_thumbnail_id_2="496"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
